Urvashi Nath
Nurse Practitioner · Deland, FLNPI 1336990175
Payments from drug & device makers
Across 136 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$247
- Radius Health, Inc.$199
- Lilly USA, LLC$189
- IBSA Pharma Inc.$187
- Xeris Pharmaceuticals, Inc.$183
- Medtronic$180
- plus $2K from 23 others
What the payments were for
- Food & beverage$2,825100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $247 |
| Radius Health, Inc. | 8 | $199 |
| Lilly USA, LLC | 11 | $189 |
| IBSA Pharma Inc. | 11 | $187 |
| Xeris Pharmaceuticals, Inc. | 9 | $183 |
| Medtronic | 8 | $180 |
| Abbott | 8 | $176 |
| Tandem Diabetes Care, Inc. | 6 | $169 |
| Amgen | 8 | $163 |
| Boehringer Ingelheim | 6 | $127 |
| Astellas Pharma US Inc | 6 | $115 |
| Bayer | 4 | $107 |
| AbbVie | 6 | $102 |
| Sanofi-aventis U.S. LLC | 3 | $86 |
| Corcept Therapeutics | 4 | $82 |
| Tolmar, Inc. | 4 | $72 |
| Recordati_rare_diseases_inc. | 3 | $58 |
| Dexcom, Inc. | 2 | $54 |
| Alvogen Inc | 3 | $52 |
| Amneal Pharmaceuticals LLC | 3 | $47 |
| BETA Bionics, Inc. | 2 | $43 |
| Sequel Med Tech, LLC | 1 | $34 |
| Almatica Pharma LLC | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| AstraZeneca | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
How this compares
$2,825 in reported general payments places this provider in the 85th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 39 | $58,504 |
| MounjaroTirzepatide | 29 | $48,240 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 21 | $44,173 |
| JardianceEmpagliflozin | 21 | $29,467 |
| SynthroidLevothyroxine Sodium | 21 | $1,923 |
| Levothyroxine Sodium | 47 | $608 |
| LevoxylLevothyroxine Sodium | 12 | $498 |
| Metformin Hcl | 24 | $188 |
| Metformin Hcl ErMetformin Hcl | 12 | $101 |
| Pioglitazone Hcl | 13 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $247 | $58,50439 claims |
| Lilly USA, LLCMounjaro | $189 | $48,24029 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $86 | $44,17321 claims |
| Boehringer IngelheimJardiance | $127 | $29,46721 claims |
| AbbVieSynthroid | $102 | $1,92321 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $47 | $60847 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Deland
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.